Immunohistochemistry Cathepsin D Test: Advanced Cancer Biomarker Analysis
Understanding the Immunohistochemistry Cathepsin D Test
The Immunohistochemistry Cathepsin D Test represents a cutting-edge diagnostic approach in modern oncology that provides critical insights into cancer behavior and progression. This specialized laboratory procedure utilizes advanced immunohistochemistry techniques to detect and quantify the expression of Cathepsin D, a lysosomal aspartic protease that plays a pivotal role in cancer development and metastasis.
Cathepsin D has emerged as a significant biomarker in various cancers, particularly breast cancer, where its expression levels correlate with tumor aggressiveness and patient prognosis. The test’s importance lies in its ability to provide molecular-level information that traditional pathology examinations cannot capture, enabling more precise cancer characterization and personalized treatment planning.
What the Test Measures and Detects
The Immunohistochemistry Cathepsin D Test specifically measures:
- Presence and distribution of Cathepsin D protein in tumor tissue
- Expression intensity and pattern within cancer cells
- Cellular localization (cytoplasmic vs. nuclear staining)
- Percentage of positive tumor cells
- Correlation with tumor grade and stage
This comprehensive analysis helps identify cancers with elevated Cathepsin D expression, which is associated with increased invasive potential, higher metastatic risk, and poorer clinical outcomes in certain cancer types.
Who Should Consider This Test
The Immunohistochemistry Cathepsin D Test is particularly valuable for patients with:
- Newly diagnosed breast cancer cases
- Aggressive or recurrent malignancies
- Cancers with unclear prognostic indicators
- Patients being evaluated for targeted therapy options
- Cases requiring additional prognostic information beyond standard markers
- Patients with family history of aggressive cancers
Clinical Indications Include:
- Breast cancer diagnosis and staging
- Prognostic assessment in various carcinomas
- Evaluation of treatment response markers
- Research and clinical trial eligibility determination
Benefits of Taking the Test
Choosing the Immunohistochemistry Cathepsin D Test provides numerous advantages for comprehensive cancer care:
Enhanced Diagnostic Precision
The test offers molecular-level insights that complement traditional pathology, providing a more complete picture of tumor biology and behavior.
Improved Prognostic Accuracy
By assessing Cathepsin D expression levels, healthcare providers can better predict disease progression and potential treatment responses.
Personalized Treatment Planning
The results help oncologists tailor treatment strategies based on individual tumor characteristics, potentially improving therapeutic outcomes.
Early Risk Assessment
Identification of high Cathepsin D expression can alert clinicians to more aggressive cancer subtypes, enabling earlier intervention strategies.
Understanding Your Test Results
Your Immunohistochemistry Cathepsin D Test results will be interpreted by experienced pathologists and oncologists. The report typically includes:
Interpretation Guidelines:
- Positive Result: Indicates significant Cathepsin D expression, which may suggest more aggressive tumor behavior in certain cancers
- Negative Result: Suggests low or absent Cathepsin D expression, which may be associated with better prognosis in specific cancer types
- Staining Intensity: Graded from weak to strong, providing additional prognostic information
- Distribution Pattern: Describes how the protein is distributed within the tumor tissue
It’s crucial to discuss your results with your healthcare provider, who will interpret them in the context of your specific medical history, other test results, and clinical presentation.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Immunohistochemistry Cathepsin D Test | $76 USD | $112 USD |
Nationwide Testing Availability
GGC DNA provides comprehensive Immunohistochemistry Cathepsin D testing services across all major cities in the United States. Our state-of-the-art laboratories and experienced pathology teams ensure accurate and timely results for patients nationwide.
Major Service Locations Include:
- New York City and surrounding areas
- Los Angeles and Southern California
- Chicago and Midwest regions
- Houston and Texas metropolitan areas
- Miami and Florida locations
- All other major US cities
Sample Requirements and Processing
For accurate testing, please provide:
- Tumor tissue preserved in 10% formal-saline OR formalin-fixed paraffin-embedded block
- Complete histopathology report
- Detailed biopsy site information
- Comprehensive clinical history
Turnaround Times:
- Standard tissue biopsy: 5 days
- Large complex tissue samples: 7 days
- Daily sample acceptance until 6 PM
Take Control of Your Cancer Care Today
The Immunohistochemistry Cathepsin D Test represents a significant advancement in cancer diagnostics, providing crucial information that can influence treatment decisions and improve patient outcomes. With our discounted price of only $76 USD and comprehensive nationwide coverage, accessing this advanced testing has never been more convenient.
Ready to schedule your test? Contact our dedicated healthcare team today at +1(267) 388-9828 or book your appointment online. Our experienced specialists are available to answer your questions and guide you through the testing process.
Don’t wait to get the comprehensive cancer insights you need. Book your Immunohistochemistry Cathepsin D Test now and take the first step toward personalized, evidence-based cancer care.
